Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 17 - Number 11

Recent Insights into Notch Signaling in Embryonal Rhabdomyosarcoma

, 17(11): 1235 - 1244

Beatrice Conti, Katherine K. Slemmons, Rossella Rota and Corinne M. Linardic

DOI: 10.2174/1389450116666150907105756

Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?

, 17(11): 1252 - 1264

Karly C. Sourris, Henry Yao, George Jerums, Mark E.Cooper, Elif I. Ekinci and Melinda T. Coughlan

DOI: 10.2174/1389450116666150722141418

Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function

, 17(11): 1275 - 1281

Kavisha Arora and Anjaparavanda P. Naren

DOI: 10.2174/1389450117666151209114343

Optimal Sequencing of New Drugs in Metastatic Castration-Resistant Prostate Cancer: Dream or Reality?

, 17(11): 1301 - 1308

Orazio Caffo, Andrea Lunardi, Chiara Trentin, Francesca Maines, Antonello Veccia and Enzo Galligioni

DOI: 10.2174/1389450117666160101121317

Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies

, 17(11): 1309 - 1328

Krishna A. Adeshara, Arundhati G. Diwan and Rashmi S. Tupe

DOI: 10.2174/1389450117666151209124007


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog